CCL19-IgG Prevents Allograft Rejection by Impairment of Immune Cell Trafficking-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CCL19-IgG Prevents Allograft Rejection by Impairment of Immune Cell Trafficking

Published:2006-08-09 Issue:9 Volume:17 Page:2521-2532
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Ziegler Ekkehard,Gueler Faikah,Rong Song,Mengel Michael,Witzke Oliver,Kribben Andreas,Haller Hermann,Kunzendorf Ulrich,Krautwald Stefan

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference51 articles.

1. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression

2. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin

3. CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs

4. Mice Lacking Expression of Secondary Lymphoid Organ Chemokine Have Defects in Lymphocyte Homing and Dendritic Cell Localization

5. Tolerogenic Dendritic Cells

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL19‐Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase;Arthritis & Rheumatology;2024-03-21

2. An explorative study of inflammation-related proteins associated with kidney injury in male heat-stressed workers;Journal of Thermal Biology;2023-02

3. Arteriovenous Fistulae in Chronic Kidney Disease and the Heart: Physiological, Histological, and Transcriptomic Characterization of a Novel Rat Model;Journal of the American Heart Association;2022-10-18

4. B Cell Activating Factor (BAFF) Is Required for the Development of Intra-Renal Tertiary Lymphoid Organs in Experimental Kidney Transplantation in Rats;International Journal of Molecular Sciences;2020-10-28

5. Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells;Journal for ImmunoTherapy of Cancer;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3